Back to top

Is Arcturus Therapeutics Holdings Inc (ARCT) Worth the Investment After Q2 Earnings Miss? EPS: ...

Is Arcturus Therapeutics Holdings Inc (ARCT) Worth the Investment After Q2 Earnings Miss? EPS: -0.84, Revenue: $3.0M, GF Score: 54/100, 57.9% Overvalued

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Arcturus Therapeutics Holdings Inc. (ARCT)